Karolinska Institutet, Department of Oncology-Pathology, SciLifeLab, Lehtiö research group;
Karolinska Institutet, Department of Medicine, Huddinge, Hellström-Lindberg research group
This postdoc position is part of the KI-SciLifeLab Clinical Translational Postdoc Program with the purpose of promoting interaction between the Science for Life Laboratory (SciLifeLab) research environment and clinical research environments at Karolinska Institutet. The postdocs that are recruited to the program will form a network with the support of the SciLifeLab Committee KI. The postdoctoral candidate will be associated in both departments to benefit from our collaborating research expertise and carry out an exciting project with translational aim.
The Department of Oncology-Pathology and the Department of Medicine, Huddinge conduct basic, translational and clinical research in a variety of areas and undergraduate and graduate education.
The position will be jointly appointed between the Cancer proteomics Mass spectrometry research group headed by Professor Janne Lehtiö at SciLifeLab/Karolinska Institutet and the Myelodysplastic Syndromes research group headed by Professor Eva Hellström-Lindberg at Karolinska Institutet. Karolinska Institutet is one of the world’s leading medical universities, and one of the four founding universities for SciLifeLab which is today a national infrastructure and research center in technology driven life sciences. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
The Lehtiö group is a translational group of scientists with a drive to improve personalized cancer medicine by multi-omics and proteomics analyses via new methods, biological understanding and clinical implantation. The Hellström-Lindberg group has a long research history on investigating the molecular pathways underlying aberrant stem cell function and ineffective cell differentiation in myelodysplastic syndromes (MDS) through high-throughput methods and focused functional approaches.
At present we seek to strengthen our groups’ joint focus on the translational research of MDS with an outstanding scientist with proven expertise in analysis of immune cell activation, with additional merits with experience on interpretation of omics data and the investigation of primary patient samples using flow cytometry and cell sorting techniques. We offer a very stimulating and diverse work in a highly collaborative team of very motivated co-workers with expertise in cutting-edge technology.
We are looking for an outstanding, enthusiastic postdoc with strong molecular and laboratory skills who wants to work at the intersection of immunology and cancer/hematology research. The aim is to generate novel knowledge about MDS biology, explore the antigen profile upon stem cell mutation and associate these findings with emerging anti-cancer therapies, particularly towards targeted immunotherapies. The postdoc candidate is also expected to be instrumental in the elaboration of hypotheses and designs to facilitate the translation of the work into new clinical initiatives.
Tasks for the position:
To be eligible for employment as a postdoctor a phd or a foreign degree deemed to be equivalent to a Swedish phd is required. This eligibility requirement must be fulfilled at the latest at the time of the employment decision. It is considered as an advantage if you have completed your doctoral degree within the last three years, if there are special reasons, your degree may have been completed earlier.
Qualifications
Additional merits
Since the position involves close interaction with several researchers, emphasis is also placed on personal skills such as:
Bases of assessment
In assessing the candidates, suitability for the position, experience in the above-specified methods, and experience in the field, will form the basis for the selection of this recruitment.
A creative and inspiring environment with wide-ranging expertise and interests. Karolinska Institutet is one of the world's leading medical universities. At Karolinska Institutet, we conduct successful medical research and hold the largest range of medical education in Sweden. At KI, you get to meet researchers working with a wide range of specialisms and methods, giving you ample opportunity to exchange knowledge and experience with the various scientific fields within medicine and health. It is the crossover collaborations, which have pushed KI to where it is today, at the forefront of global research. Several of the people you meet in healthcare are educated at KI. A close relationship with the health care providers is important for creating groundbreaking top quality education and research. Karolinska Institutet is also a state university, which entitles you to several benefits through our collective agreement.
Location: Science for Life Laboratory, SciLifeLab in Solna
Choose to work at KI – Ten reasons why
An employment application must contain the following documents in English or Swedish:
Welcome to apply at the latest 19th January.
The application is to be submitted through the Varbi recruitment system.
This is a 2 year position. With possibility of extension.
Type of employment | Temporary position |
---|---|
Contract type | Full time |
First day of employment | Up on Agreement |
Salary | Monthly salary |
Number of positions | 1 |
Full-time equivalent | 100 % |
City | Solna |
County | Stockholms län |
Country | Sweden |
Reference number | STÖD 2-5103/2024 |
Contact |
|
Union representative |
|
Published | 18.Dec.2024 |
Last application date | 19.Jan.2025 11:59 PM CET |